AIP
BSX icon

Almanack Investment Partners’s Boston Scientific BSX Stock Holding History

Almanack Investment Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,434
Closed -$56K – 316
2022
Q3 		$56K Buy
+1,434
New +$57.5K 0.01% 247
2019
Q3 		– Sell
-2,665
Closed -$115K – 243
2019
Q2 		$115K Buy
+2,665
New +$103K 0.03% 252

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Almanack Investment Partners's BSX Position: Q4 2022 in Review

Almanack Investment Partners sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 1,434 shares — an estimated $56K sold.

Almanack Investment Partners first reported a position in BSX in Q2 2019 and held it in 2 quarters. The position peaked at $115K in Q2 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Almanack Investment Partners reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,434 Boston Scientific shares in Q4 2022, an estimated $56K.
  • Almanack Investment Partners first reported a position in Boston Scientific in Q2 2019 and held it in 2 quarters.
  • Almanack Investment Partners's Boston Scientific position peaked at $115K in Q2 2019.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.